Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
about
Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, an agricultural azole.Ibuprofen potentiates the in vivo antifungal activity of fluconazole against Candida albicans murine infectionSynergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicansDiagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question?Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy.Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Sedaxicenes: potential new antifungal ferrocene-based agents?Persistence and drug tolerance in pathogenic yeast.An overview about the medical use of antifungals in Portugal in the last years.Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles.First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States.Transcriptional profiling of azole-resistant Candida parapsilosis strainsSpecies distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.Prevention of invasive Candida infections in preterm infants: the time is now.Does fungicide application in vineyards induce resistance to medical azoles in Aspergillus species?Evolution of cross-resistance to medical triazoles in Aspergillus fumigatus through selection pressure of environmental fungicides.
P2860
Q35185695-F13857D2-F906-44CE-BAB9-A5548651B3CAQ35746053-E0427827-8154-4AD3-988F-C2191FD1E5E6Q35875686-7FEB0DA9-7973-4A74-AF0B-D87F674FD8CCQ37650317-0EF7CF8F-7205-4ED8-B4B4-6F873BEA8029Q37657464-24DA059C-15A6-45CD-900A-0A4DE2B28270Q37859397-D24247B8-2FCB-4B7D-BB69-B4BD2B5F8A10Q37900678-7351C3F9-70C0-457E-9B13-9FE17DA673C8Q38206867-6ED5BA5B-A8F6-4194-A376-BCF123FA91FCQ38589279-8633E2AA-78C9-4678-92E6-8E3F09753217Q38787319-11CE916E-E36F-48B5-972E-1CF14329E4D0Q38837629-CFF3E74C-0DD3-447A-B918-B00E8B4D5774Q40796297-B9FAE74D-77B4-4EED-BD97-7979EF4DEAA3Q41370116-871FA593-66B0-4A0E-97C9-289FC025DEA6Q41842226-7EA99BD6-0812-4D2B-B998-1C5E9CD0A395Q42110990-3B4FB1F9-C159-4DF3-8637-C8545D4D41E2Q45896960-B760452A-14D6-407C-A77D-1679F391846FQ46459098-A13CD81A-7254-429D-A7BC-16BC2A57041AQ46893764-E26005CD-85A9-492E-A137-BF77BF29F801Q53725145-41BA68E7-EDA9-4071-A1BD-FB292301F508
P2860
Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is there a serious risk of res ...... azole antifungals in medicine?
@en
Is there a serious risk of res ...... azole antifungals in medicine?
@nl
type
label
Is there a serious risk of res ...... azole antifungals in medicine?
@en
Is there a serious risk of res ...... azole antifungals in medicine?
@nl
prefLabel
Is there a serious risk of res ...... azole antifungals in medicine?
@en
Is there a serious risk of res ...... azole antifungals in medicine?
@nl
P1476
Is there a serious risk of res ...... azole antifungals in medicine?
@en
P2093
Herbert Hof
P356
10.1016/J.DRUP.2008.01.001
P577
2008-02-01T00:00:00Z